These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3325254)

  • 1. Development of resistance to ofloxacin.
    Crumplin GC; Odell M
    Drugs; 1987; 34 Suppl 1():1-8. PubMed ID: 3325254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ofloxacin: in vitro and in vivo activity.
    Guerra L; Caro B; Erani E; Xerri L
    Chemioterapia; 1987 Feb; 6(1):23-31. PubMed ID: 3470154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and expression of mutational resistance to the 4-quinolone antibacterials.
    Smith JT
    Scand J Infect Dis Suppl; 1986; 49():115-23. PubMed ID: 3547618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of the sensitivity of bacteria of various origin to ofloxacin.
    Gubina M
    Chemioterapia; 1987 Apr; 6(2):79-81. PubMed ID: 3474082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo selection during ofloxacin therapy of Escherichia coli with combined topoisomerase mutations that confer high resistance to ofloxacin but susceptibility to nalidixic acid.
    Cattoir V; Lesprit P; Lascols C; Denamur E; Legrand P; Soussy CJ; Cambau E
    J Antimicrob Chemother; 2006 Nov; 58(5):1054-7. PubMed ID: 16984897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ofloxacin: antibacterial activity, induction of resistance and killing curves.
    Husson MO; Izard D; Bryskier A; Leclerc H
    Chemioterapia; 1985 Aug; 4(4):278-83. PubMed ID: 3863716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Monk JP; Campoli-Richards DM
    Drugs; 1987 Apr; 33(4):346-91. PubMed ID: 3297617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-bacterial effect of ofloxacin--in vitro and in vivo results].
    Altay G; Tulunay C
    Mikrobiyol Bul; 1985 Oct; 19(4):183-9. PubMed ID: 3868736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative in vitro activity of ciprofloxacin, ofloxacin and pefloxacin against resistant clinical isolates.
    Periti P; Mazzei T; Nicoletti P
    Chemioterapia; 1987 Apr; 6(2):75-8. PubMed ID: 3474081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antibacterial activity of imipenem in combination with newer quinolone derivatives.
    Kern W; Gulden H; Vanek E; Kurrle E
    Chemotherapy; 1988; 34(2):117-26. PubMed ID: 3164670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Susceptibilities of clinical isolates to antibacterial agents. Focusing mainly on ofloxacin (first report). Reported by the Research Group for Testing Ofloxacin Susceptibility of Clinical Isolates].
    Kosakai N
    Jpn J Antibiot; 1988 Jan; 41(1):71-104. PubMed ID: 3163383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The sensitivity of gram-negative and gram-positive bacteria to ofloxacin.
    Speciale A; Stefani S; Caccamo F; Nicolosi VM; Nicoletti G
    Drugs Exp Clin Res; 1987; 13(9):555-61. PubMed ID: 3480796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro study of the antibacterial activity of ofloxacin against recent clinical isolates.
    Varoli O; Ferri M
    Drugs Exp Clin Res; 1987; 13(4):209-12. PubMed ID: 3476290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro antibacterial activity and pharmacokinetics of ofloxacin in chronic respiratory tract infections].
    Sugimoto Y; Matsumoto Y; Hitsuda Y; Yamamoto Y; Ishitobi K; Sasaki T
    Jpn J Antibiot; 1987 Feb; 40(2):325-30. PubMed ID: 3474429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sensitivity of gram-negative and gram-positive bacteria to ofloxacin.
    Speciale A; Stefani S; Caccamo F; Nicolosi VM; Nicoletti G
    Chemioterapia; 1987 Feb; 6(1):17-22. PubMed ID: 3470153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International experiences with ofloxacin, a new quinolone.
    Mitsuhashi S
    Infection; 1986; 14 Suppl 4():S223-5. PubMed ID: 3028965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ofloxacin, a bactericidal antibacterial.
    Smith JT
    Chemotherapy; 1991; 37 Suppl 1():2-13. PubMed ID: 1646700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility in vitro of gram-positive aerobe and anaerobe bacteria to ofloxacin.
    Debbia E; Mannelli S; Gianrossi G; Schito GC
    Drugs Exp Clin Res; 1987; 13(4):213-7. PubMed ID: 3304918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The antibacterial activity in vitro of ofloxacin in comparison with other orally administered antimicrobial substances on ampicillin-resistant clinical isolates].
    Seibert G; Klesel N; Limbert M; Schrinner E; Winkler I
    Arzneimittelforschung; 1984; 34(11):1552-4. PubMed ID: 6596953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.